Literature DB >> 21079627

Ten years of the Global Alliance for Vaccines and Immunization: challenges and progress.

John Clemens1, Jan Holmgren, Stefan H E Kaufmann, Alberto Mantovani.   

Abstract

Diseases preventable by underused vaccines cause the death of approximately 3 million children per year. The Global Alliance for Vaccines and Immunization (GAVI) was launched 10 years ago to tackle this appalling situation.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21079627     DOI： 10.1038/ni1210-1069

Source DB:  PubMed          Journal:  Nat Immunol        ISSN： 1529-2908            Impact factor:   25.606


  10 in total

1.  The Global Alliance for Vaccines and Immunization--a millennial challenge.

Authors:  G J Nossal
Journal:  Nat Immunol       Date:  2000-07       Impact factor: 25.606

2.  Rotavirus: realising the potential of a promising vaccine.

Authors:  E Anthony S Nelson; Roger I Glass
Journal:  Lancet       Date:  2010-08-06       Impact factor: 79.321

Review 3.  Changing funding patterns in tuberculosis.

Authors:  Stefan H E Kaufmann; Shreemanta K Parida
Journal:  Nat Med       Date:  2007-03       Impact factor: 53.440

4.  An assessment of interactions between global health initiatives and country health systems.

Authors:  Badara Samb; Tim Evans; Mark Dybul; Rifat Atun; Jean-Paul Moatti; Sania Nishtar; Anna Wright; Francesca Celletti; Justine Hsu; Jim Yong Kim; Ruairi Brugha; Asia Russell; Carissa Etienne
Journal:  Lancet       Date:  2009-06-20       Impact factor: 79.321

5.  GAVI enters its second decade with massive funding gap.

Authors:  Ann Danaiya Usher
Journal:  Lancet       Date:  2010-03-06       Impact factor: 79.321

6.  Effect of the Global Alliance for Vaccines and Immunisation on diphtheria, tetanus, and pertussis vaccine coverage: an independent assessment.

Authors:  Chunling Lu; Catherine M Michaud; Emmanuela Gakidou; Kashif Khan; Christopher J L Murray
Journal:  Lancet       Date:  2006-09-23       Impact factor: 79.321

7.  Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.

Authors:  M Pizza; V Scarlato; V Masignani; M M Giuliani; B Aricò; M Comanducci; G T Jennings; L Baldi; E Bartolini; B Capecchi; C L Galeotti; E Luzzi; R Manetti; E Marchetti; M Mora; S Nuti; G Ratti; L Santini; S Savino; M Scarselli; E Storni; P Zuo; M Broeker; E Hundt; B Knapp; E Blair; T Mason; H Tettelin; D W Hood; A C Jeffries; N J Saunders; D M Granoff; J C Venter; E R Moxon; G Grandi; R Rappuoli
Journal:  Science       Date:  2000-03-10       Impact factor: 47.728

8.  Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial.

Authors:  George E Armah; Samba O Sow; Robert F Breiman; Michael J Dallas; Milagritos D Tapia; Daniel R Feikin; Fred N Binka; A Duncan Steele; Kayla F Laserson; Nana A Ansah; Myron M Levine; Kristen Lewis; Michele L Coia; Margaret Attah-Poku; Joel Ojwando; Stephen B Rivers; John C Victor; Geoffrey Nyambane; Abraham Hodgson; Florian Schödel; Max Ciarlet; Kathleen M Neuzil
Journal:  Lancet       Date:  2010-08-06       Impact factor: 79.321

9.  A cluster-randomized effectiveness trial of Vi typhoid vaccine in India.

Authors:  Dipika Sur; R Leon Ochiai; Sujit K Bhattacharya; Nirmal K Ganguly; Mohammad Ali; Byomkesh Manna; Shanta Dutta; Allan Donner; Suman Kanungo; Jin Kyung Park; Mahesh K Puri; Deok Ryun Kim; Dharitri Dutta; Barnali Bhaduri; Camilo J Acosta; John D Clemens
Journal:  N Engl J Med       Date:  2009-07-23       Impact factor: 91.245

Review 10.  Epidemic meningitis, meningococcaemia, and Neisseria meningitidis.

Authors:  David S Stephens; Brian Greenwood; Petter Brandtzaeg
Journal:  Lancet       Date:  2007-06-30       Impact factor: 79.321
  10 in total
  19 in total

1.  Lack of broad functional differences in immunity in fully vaccinated vs. unvaccinated children.

Authors:  Ashley M Sherrid; Candice E Ruck; Darren Sutherland; Bing Cai; Tobias R Kollmann
Journal:  Pediatr Res       Date:  2016-12-26       Impact factor: 3.756

2.  Nonspecific effects of neonatal and infant vaccination: public-health, immunological and conceptual challenges.

Authors:  Peter Aaby; Tobias R Kollmann; Christine Stabell Benn
Journal:  Nat Immunol       Date:  2014-10       Impact factor: 25.606

3.  Overview of global, regional, and national routine vaccination coverage trends and growth patterns from 1980 to 2009: implications for vaccine-preventable disease eradication and elimination initiatives.

Authors:  Aaron S Wallace; Tove K Ryman; Vance Dietz
Journal:  J Infect Dis       Date:  2014-11-01       Impact factor: 5.226

Review 4.  Systems vaccinology: a promise for the young and the poor.

Authors:  Nelly Amenyogbe; Ofer Levy; Tobias R Kollmann
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-06-19       Impact factor: 6.237

5.  Vaccine-induced immunity in early life.

Authors:  Tobias R Kollmann; Ofer Levy; Willem Hanekom
Journal:  Vaccine       Date:  2013-04-12       Impact factor: 3.641

6.  Rational design of thermostable vaccines by engineered peptide-induced virus self-biomineralization under physiological conditions.

Authors:  Guangchuan Wang; Rui-Yuan Cao; Rong Chen; Lijuan Mo; Jian-Feng Han; Xiaoyu Wang; Xurong Xu; Tao Jiang; Yong-Qiang Deng; Ke Lyu; Shun-Ya Zhu; E-De Qin; Ruikang Tang; Cheng-Feng Qin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-15       Impact factor: 11.205

7.  Priming T-cell responses with recombinant measles vaccine vector in a heterologous prime-boost setting in non-human primates.

Authors:  Diane L Bolton; Sampa Santra; Cindy Swett-Tapia; Jerome Custers; Kaimei Song; Harikrishnan Balachandran; Linh Mach; Hussein Naim; Pamela A Kozlowski; Michelle Lifton; Jaap Goudsmit; Norman Letvin; Mario Roederer; Katarina Radošević
Journal:  Vaccine       Date:  2012-06-22       Impact factor: 3.641

8.  Community vaccine perceptions and its role on vaccination uptake among children aged 12-23 months in the Ileje District, Tanzania: a cross section study.

Authors:  Pai Elia Chambongo; Patrick Nguku; Peter Wasswa; Innocent Semali
Journal:  Pan Afr Med J       Date:  2016-04-06

9.  Variation between Populations in the Innate Immune Response to Vaccine Adjuvants.

Authors:  Tobias R Kollmann
Journal:  Front Immunol       Date:  2013-04-02       Impact factor: 7.561

10.  Evaluation of medicine retail outlets for sale of typhoid fever vaccine among adults in two urban and rural settings in western Kenya: a proof-of-concept study.

Authors:  Julius Ho; Gladys Odhiambo; Lucy W Meng'anyi; Rosemary M Musuva; Joseph M Mule; Zakayo S Alaly; Maurice R Odiere; Pauline N Mwinzi; Lisa Ganley-Leal
Journal:  BMC Health Serv Res       Date:  2016-09-29       Impact factor: 2.655
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.